Fracture in Irradiated Rat Femur: A Description of an Experimental Model and Evaluation of its Effectiveness.

Objective We aim to describe an experimental model for studying femoral fractures in rats after exposure to ionizing radiation, demonstrating a way to apply a substance for analysis, the method for patterning fracture and irradiation, and how to evaluate its effectiveness based on radiographic studies. Methods We used 24 rats divided into 2 groups of 12 animals each. The STUDY group was exposed to ionizing radiation and treated with saline solution, and the CONTROL group was not exposed to radiation and was treated with saline solution. All animals were subjected to standardized fracture of the right femur that was fixed with intramedullary wire. The efficiency of the bone union was assessed by radiographic exam. Results Fracture healing was more efficient in bones not exposed to ionizing radiation ( p = 0.012). All fractures met the criteria of being simple, diaphyseal, transverse or short oblique. Conclusion The experimental model presented is an efficient alternative for the study of fractures in irradiated bones in rats.

Fracture in Irradiated Rat Femur: A Description of an Experimental Model and Evaluation of its Effectiveness / Fratura em fêmur irradiado de rato: Descrição de um modelo experimental e avaliação de sua eficácia

Abstract Objective We aim to describe an experimental model for studying femoral fractures in rats after exposure to ionizing radiation, demonstrating a way to apply a substance for analysis, the method for patterning fracture and irradiation, and how to evaluate its effectiveness based on radiographic studies. Methods We used 24 rats divided into 2 groups of 12 animals each. The STUDY group was exposed to ionizing radiation and treated with saline solution, and the CONTROL group was not exposed to radiation and was treated with saline solution. All animals were subjected to standardized fracture of the right femur that was fixed with intramedullary wire. The efficiency of the bone union was assessed by radiographic exam. Results Fracture healing was more efficient in bones not exposed to ionizing radiation (p = 0.012). All fractures met the criteria of being simple, diaphyseal, transverse or short oblique. Conclusion The experimental model presented is an efficient alternative for the study of fractures in irradiated bones in rats.

Resumo Objetivo Nosso objetivo é descrever um modelo experimental para estudo de fraturas de fêmur em ratos após exposição a radiação ionizante, demonstrando uma forma de aplicação de uma substância para análise, o método de padronização de fratura e irradiação e a forma de avaliação de sua eficácia com base em estudos radiográficos. Métodos Utilizamos 24 ratos divididos em dois grupos de 12 animais cada. O grupo ESTUDO foi exposto à radiação ionizante e tratado com soro fisiológico, enquanto o grupo CONTROLE não foi exposto à radiação e foi tratado com soro fisiológico. Todos os animais foram submetidos à fratura padronizada do fêmur direito e sua fixação com fio intramedular. A eficácia da consolidação óssea foi determinada por exame radiográfico. Resultados A cicatrização de fraturas foi mais eficiente em ossos não expostos à radiação ionizante (p = 0,012). Todas as fraturas atenderam aos critérios de serem simples, diafisárias, transversas ou oblíquas curtas. Conclusão O modelo experimental apresentado é uma boa alternativa para o estudo de fraturas em ossos irradiados em ratos.

Multiple Myeloma (Part 2) - Update on The Approach to Bone Disease.

The increase in life expectancy of the world population has led to a concomitant increase in the prevalence of multiple myeloma (MM), a disease that usually affects the elderly population. Bone lesions are frequent in patients with this condition, demanding an early approach, from drug treatment, through radiotherapy to orthopedic surgery (prophylactic or therapeutic) with the objective of preventing or delaying the occurrence of fracture, or, when this event has already occurred, treat it through stabilization or replacement (lesions located in the appendicular skeleton) and/or promote stabilization and spinal cord decompression (lesions located in the axial skeleton), providing rapid pain relief, return to ambulation and resocialization, returning quality of life to patients. The aim of this review is to update the reader on the findings of pathophysiology, clinical, laboratory and imaging, differential diagnosis and therapeutic approach of multiple myeloma bone disease (MMBD).

Linfoma gástrico primario a células T, no asociado a HTLV1, con presentación inicial de fractura patológica. Reporte de caso

El linfoma de células T en adultos (ATLL) es una neoplasia agresiva de linfocitos T, por lo general asociada con el virus linfotrópico T humano tipo 1 (HTLV-1), de presentación clínica abigarrada. Los linfomas gástricos primarios son generalmente linfoma no Hodgkin (NH) tipo B, y un mínimo porcentaje por linfocitos T. Es escasa la literatura sobre linfomas gástricos primarios por células T con HTLV-1 Negativo y que hacen metástasis ósea. Para ilustrar esta situación, se presenta el caso de un adulto de 41 años, que ingresa por una fractura patológica. A los 15 días presenta diarrea, distensión abdominal, y una endoscopia alta encuentra "Lesiones ulceradas gástricas, aspecto neoproliferativo". La biopsia informó Linfoma No Hodgkin a células maduras linfocito T; y la prueba de HTLV1 fue negativa. Se realizaron tres sesiones de quimioterapia con esquema CHOEP. Hubo respuesta favorable, saliendo de alta; sin embargo, no retorna para proseguir la terapia. El paciente regresó dos meses después en mal estado general; luego presentó falla multiorgánica, produciéndose su deceso.

Adult T-cell lymphoma (ATLL) is an aggressive T-cell neoplasm, usually associated with human T-lymphotropic virus type 1 (HTLV-1), with a variegated clinical presentation. Primary gastric lymphomas are generally non-Hodgkin lymphoma (NH) type B, and a minimal percentage are due to T lymphocytes. There is little literature on primary gastric lymphomas due to HTLV-1 Negative T cells that metastasize to bone. To illustrate this situation, the case of a 41-year-old adult who is admitted for a pathological fracture is presented. 15 days later, he developed diarrhea and abdominal distension, and an upper endoscopy found "gastric ulcerated lesions, neoproliferative appearance". The Biopsy reported Non-Hodgkin Lymphoma to mature T lymphocyte cells; and the HTLV1 test was negative. Three chemotherapy sessions were performed with the CHOEP scheme. There was a favorable response, and he was discharged; However, he did not return to continue therapy. The patient returned 2 months later in poor general condition. He then presented multiple organ failure, resulting in his death.

Multiple Myeloma (Part 2) - Update on The Approach to Bone Disease / Mieloma múltiplo (Parte 2) - Atualização sobre a abordagem da doença óssea

Abstract The increase in life expectancy of the world population has led to a concomitant increase in the prevalence of multiple myeloma (MM), a disease that usually affects the elderly population. Bone lesions are frequent in patients with this condition, demanding an early approach, from drug treatment, through radiotherapy to orthopedic surgery (prophylactic or therapeutic) with the objective of preventing or delaying the occurrence of fracture, or, when this event has already occurred, treat it through stabilization or replacement (lesions located in the appendicular skeleton) and/or promote stabilization and spinal cord decompression (lesions located in the axial skeleton), providing rapid pain relief, return to ambulation and resocialization, returning quality of life to patients. The aim of this review isto update the reader on the findings of pathophysiology, clinical, laboratory and imaging, differential diagnosis and therapeutic approach of multiple myeloma multiple myeloma bone disease (MMBD).

Resumo O aumento da expectativa devida da população mundial levou a incremento concomitante na prevalência de mieloma múltiplo (MM), patologia que geralmente afeta a população idosa. Lesões ósseas são frequentes nos portadores desta condição, demandando abordagem precoce, desde o tratamento medicamentoso, passando pela radioterapia até a cirurgia ortopédica (profilática ou terapêutica) com os objetivos de prevenir ou retardar a ocorrência de fratura, ou, quando este evento já ocorreu, tratá-la mediante estabilização ou substituição (lesões situadas no esqueleto apendicular) e/ou promover estabilização e descompressão medular (lesões situadas no esqueleto axial), proporcionando rápido alívio da dor, retorno à deambulação e ressocialização, devolvendo a qualidade de vida aos pacientes. O objetivo desta revisão é atualizar o leitor sobre a fisiopatologia, a clínica, exames laboratoriais e de imagem, diagnóstico diferencial e abordagem terapêutica da doença óssea no mieloma múltiplo (DOMM).

[Impact of osteoporosis on physical performance parameters of middle-aged and elderly individuals-a cross-sectional study]. / Einfluss von Osteoporose auf physische Leistungsparameter von Personen im mittleren und höheren Lebensalter ­ eine Querschnittstudie.

BACKGROUND: Osteoporosis (OP) in the elderly is accompanied by reduced muscle mass and reduced muscle strength, also known as sarcopenia. This results in functional limitations and a high risk of falls and injuries. The determination of physical performance parameters such as grip strength and trunk strength on the one hand, and balance abilities on the other, provide information about the individual's general neuromuscular condition and serve as an indicator of physical performance in the elderly. The extent to which previous osteoporotic vertebral fractures (VFs) restrict an individual's physical performance has not been adequately investigated yet. MATERIAL AND METHODS: In total, 118 persons, with a mean age of 71.5 ± 9 years, participated in the clinical trial (ethics committee approval number A2020-0041). Patients were divided into an OP group (58 patients) and a control group (CG; 60 patients). OP patients with (VFs) and without vertebral fractures (0VFs) were viewed separately in the subgroup analysis. Data concerning physical status, including hand grip strength (HGS), the chair-rising test (CRT), tandem stance (TS), tandem gait (TG), and single-leg stance (SLS) were available for all patients. All data were analyzed using SPSS, Version 23.0. RESULTS: No significant difference (p > 0.05) was registered between the OP and CG groups with regard of HGS, CRT, TG, TS, and SLS. In the subgroup analysis, OP patients with VFs had a lower HGS than OP patients without 0 VFx (VFs 24.3 ± 10.2 kg vs. 0 VFs 29.7 ± 9.5 kg, p = 0.026). TS was maintained longer by OP patients 0 VFs (VFs 7.8 ± 3.2 s vs. 0 VFs 9.5 ± 1.8 s, p = 0.008). The latter were also able to maintain their balance in TG over more numerous steps (VFs 4.8 ± 3.0 vs. 0 VFs 6.7 ± 2.4, p = 0.011). In a regression analysis, body size, gender, and age were shown to be independent factors influencing HGS (p < 0.001). CONCLUSION: Patient age, constitution, and gender have a relevant influence on HGS, with baseline conditions after diagnosed OP at comparable levels in this age group. In a subgroup of OP patients with VFs, there is a close relationship between bone and muscle with an increasing deterioration of the musculoskeletal system. For prophylaxis of osteosarcopenia, early training seems reasonable.

Etiopathogenesis of pathological mandibular fracture: literature review and case reports / Etiopatogenia da fratura patológica mandibular: revisão de literatura e relatos de caso

ABSTRACT Pathological mandibular fractures are fractures induced by pathologies affecting the mandible's base or those resulting from forces that would typically be tolerable if the bone were not compromised by an underlying condition. These fractures often present complex clinical scenarios owing to the compromised bone integrity caused by the pathology, which impedes resolution. Systemic changes may also diminish the capacity for bone neoformation, significantly limiting therapeutic options. Therefore, this study aimed to provide a comprehensive review of the published scientific literature and present clinical cases related to the treatment and prevention of pathological mandibular fractures. A literature review was conducted, focusing on case reports indexed in the MEDLINE and SCIELO databases using specific keywords as descriptors. The search yielded ten articles, which described the etiopathogenesis, classified as infectious, idiopathic, benign pathology, malignant pathology, and iatrogenic. The literature suggests that prioritizing surgery to address the underlying local pathology is crucial. Managing the remaining bone defect optimally may necessitate multiple surgical interventions. Furthermore, preventive measures should be implemented in potential iatrogenic cases. Notably, fractures of malignant, idiopathic, hereditary, and metabolic etiologies may indicate the initial manifestation of diseases.

RESUMO As fraturas patológicas mandibulares são aquelas provocadas por patologias que envolvem a base da mandíbula ou que ocorrem por forças de carga que seriam toleradas de forma normal caso o osso não fosse enfraquecido subjacentemente. Os pacientes com fraturas patológicas de mandíbula tendem a apresentar situações clínicas complexas, com limitação ou comprometimento ósseo causado pela patologia que dificulta a sua resolução bem como diminuição da capacidade de neoformação óssea pelas alterações de ordem sistêmica que podem restringir significativamente as alternativas terapêuticas. Desta forma, o objetivo do presente trabalho é revisar a literatura científica publicada e apresentar casos clínicos sobre tratamento e prevenção de fratura patológica mandibular. Uma revisão de literatura foi realizada a partir de relatos de caso indexados nas bases de dados MEDLINE e SCIELO com palavras-chave utilizadas de acordo com seus descritores específicos. A pesquisa resultou em dez artigos descrevendo como etiopatogenia causas classificadas como de origem infecciosa, idiopática, patologia benigna, patologia maligna e iatrogenia. A literatura preconiza que a cirurgia para o tratamento da patologia local seja a prioridade e que o defeito ósseo remanescente seja administrado da melhor maneira que o caso permitir, podendo ser corrigido em mais de um tempo cirúrgico. Os possíveis casos iatrogênicos devem ter condutas preventivas. Fraturas de etiologia maligna, idiopática, hereditária e metabólica apresentam a possibilidade de sinalização da primeira manifestação das doenças.

[Atypical femoral fractures due to the use of bisphosphonates. Experience of two institutions]. / Fracturas femorales atípicas por el uso de bifosfonatos. Experiencia de dos instituciones.

INTRODUCTION: bisphosphonates are used for the management of postmenopausal osteoporosis with high risk of fracture, glucocorticoid-induced osteoporosis, Paget's disease and hypercalcemia; as well as an adjuvant for the management of hyperparathyroidism. Bisphosphonates have been associated with previously unknown adverse effects, including atypical femur fractures. OBJECTIVE: to analyze the relationship of the history of bisphosphonate (BF) use as a risk factor for presenting atypical femur fractures (AFF). MATERIAL AND METHODS: patients aged 40 years or older from two hospital centers seen from 2009 to 2018 for femur fracture were included. The radiographic studies of 441 records were reviewed, from which the fracture site was defined. Subtrochanteric (SF) and diaphyseal (DF) femur fractures were analyzed applying the criteria of the second report of the American Society for Bone and Mineral Research for case definition of AFF. Finally, the consumption of bisphosphonates in these groups was investigated to estimate a measure of association. RESULTS: of the 441 clinical records, 98 (22.2%) were male and 343 (77.7%) were female with a mean age of 77.8 (40-103) years. Fifty-nine FS/FD were identified, of which 53% (31 records) were categorized as AFF. BF use was determined in 80.6% of patients with AFF and 3.57% in FS/FD. BF use was significantly associated with the presence of AFF (OR: 112, p 0.000, CI 95%: 12.6-1001). CONCLUSIONS: BF use significantly increases the risk of presenting AFF. AFF in patients who used BF occurred after a minimum consumption of 24 months.

INTRODUCCIÓN: los bifosfonatos se usan para el manejo de osteoporosis postmenopáusica con riesgo elevado de fractura, osteoporosis inducida por glucocorticoides, enfermedad de Paget e hipercalcemia; así como coadyuvante para manejo del hiperparatiroidismo. Los bifosfonatos se han asociado a efectos adversos previamente desconocidos dentro de los que se encuentran fracturas de fémur de trazo atípico. OBJETIVO: analizar la relación del antecedente de uso de bifosfonatos (BF) como factor de riesgo para presentar fracturas atípicas de fémur (FAF). MATERIAL Y MÉTODOS: se incluyeron pacientes de 40 años o más de dos centros hospitalarios atendidos desde 2009 a 2018 por fractura de fémur. Se revisaron los estudios radiográficos de 441 registros, de los cuales se definió el sitio de fractura. Se analizaron las fracturas de fémur subtrocantéricas (FS) y diafisarias (FD) aplicando los criterios del segundo reporte de la American Society for Bone and Mineral Research para la definición de caso de FAF. Finalmente, se indagó el consumo de bifosfonatos en estos grupos para para estimar una medida de asociación. RESULTADOS: de los 441 registros clínicos, 98 (22.2%) fueron del sexo masculino y 343 (77.7%) del femenino, con edad promedio de 77.8 (40-103) años. Se identificaron 59 FS/FD, de las cuales 53% (31 registros) fueron catalogadas FAF. El consumo de BF se determinó en 80.6% de pacientes con FAF y en 3.57% con FS/FD. El uso de BF se asoció significativamente con la presencia de FAF (OR: 112, p 0.000, IC 95%: 12.6-1001). CONCLUSIONES: el uso de BF aumenta significativamente el riesgo de presentar FAF. Las FAF en pacientes que usaron BF se presentó tras un consumo mínimo de 24 meses.

Fractura con hundimiento de cráneo intrauterina espontánea: reporte de dos casos / Spontaneous intrauterine depressed skull fracture: report of two cases

Las fracturas con hundimiento de cráneo intrauterinas representan una entidad poco frecuente, generalmente secundaria a traumatismos (previos o durante el nacimiento) o de etiología desconocida. Suelen requerir evaluación y seguimiento por el servicio de Neurocirugía Pediátrica. A la fecha, es controversial la necesidad de tratamiento quirúrgico y el momento oportuno para concretarlo. Se presentan dos casos clínicos de pacientes de término, nacidas porcesárea,condiagnósticoposnatalinmediatodehundimiento de cráneo de tipo ping-pong no traumático. Ambas pacientes presentaron examen neurológico normal. Se confirmó el diagnóstico a través de radiografía y tomografía de cráneo, sin observarse lesiones asociadas. Fueron valoradas por el servicio de Neurocirugía, que indicó corrección quirúrgica de la lesión en ambos casos, con buena evolución posterior.

Spontaneous intrauterine depressed skull fractures are a rare entity. They can appear secondarily to head trauma (before or during birth) or due to unknown etiology. They usually require a complete evaluation from pediatric neurosurgery specialists. Their optimal management, including timely surgical treatment remains controversial. We describe two cases delivered by cesarean section, with postnatal diagnosis of spontaneous intrauterine depressed skull fracture. Both had a normal neurological exam. A skull radiography and head CT were performed, and no associated lesions were found. Both cases required surgical correction, with positive results.

Case report of a tibial fracture in a patient suffering from gout: An atypical site, the importance of differential diagnosis.

We present the case of a 60-year-old man with a history of severe tophaceous gout with polyarticular involvement who came to the emergency room due to direct trauma to the right forearm and knee. The knee X-ray and CT scan showed a lateral tibial plateau fracture characterized by the presence of a lytic bone lesion. The presence of a solid neoplasm was ruled out and a CT-guided biopsy was performed. Histological evaluation revealed findings typical for an advanced intraosseous gout. As there was no significant risk of progression of the lytic lesion, the fracture site was treated conservatively. This case is unique in the literature in terms of location and should be considered as an atypical site of intraosseous gout. Proper differentiation of a pathological fracture on an intraosseous gout location from a neoplastic lesion is essential to choose the correct therapy.

Evaluation of Intramedullary Methods with Polymethylmethacrylate for Fixation of Bone Lesions of the Extremities.

Objective To evaluate the better potential and functional results in pain control in the treatment of pathological fractures and prophylactic fixation with an intramedullary nail associated with polymethylmethacrylate, compared with the utilization of an intramedullary nail in long bone tumor lesions. Methods From January 2012 to September 2017, 38 patients with 42 pathological lesions (fractures or impending fractures according to the Mirels criteria) were treated surgically. Sixteen patients allocated to the control group underwent a locked intramedullary nail fixation, and 22 patients with pathological lesions were allocated to treatment with an intramedullary nail associated with polymethylmethacrylate. Postoperatively, the patients were submitted to the Musculoskeletal Tumor Society (MSTS) rating scale, radiographic assessment, and to the assessment of events and complications related to the treatment. Results The evaluation using the MSTS questionnaire showed better functional results in the group associated with polymethylmethacrylate, in comparison with the control group, which obtained an average score of 16.375 out of a maximum of 30 points (54.6%). The group studied with association with polymethylmethacrylate obtained a mean of 22.36 points (74.5%). The procedure proved to be safe, with similar complication and severity rates, and with no statistical difference in comparison with the standard treatment. Conclusion Stabilization of tumor lesions with an internal fixation associated with the polymethylmethacrylate demonstrated early rehabilitation and improved the quality of life, allowing rapid functional recovery. The use of polymethylmethacrylate has advantages such as reduced bleeding, tumor necrosis and higher mechanical stability.

Non-Secretory Multiple Myeloma with Patchy Marrow Involvement and Aberrant Cytokeratin Expression.

Non-secretory multiple myeloma is a rare form of the disease that presents a diagnostic challenge. A 69-year-old woman presented to the emergency department with a pathological fracture of the right clavicle, along with a history of asthenia and middle back pain in the preceding three months. Workup revealed multiple focal lytic bone lesions in the clavicles, ribs, skull and thoracic- lumbar-sacral spine, without evidence of anemia, hypercalcemia or renal failure, with no abnormal immunofixation in the serum or urine and with normal serum free light chain ratios. The Iliac crest bone marrow aspiration and biopsy revealed a scarcely involved marrow, However, biopsy of one of the focal bone lesions revealed a hypercellular bone marrow with phenotypically abnormal plasmocytes, along with an intriguing, albeit aberrant, cytokeratin expression. Non-secretory multiple myeloma is in itself a rare diagnosis. However, the combination of a patchy marrow involvement and aberrant cytokeratin expression makes this a noteworthy presentation.

O mieloma múltiplo não-secretor é uma forma rara da doença e um desafio diagnóstico. Uma mulher de 69 anos recorreu ao serviço de urgência com uma fratura patológica da clavícula direita e uma história de astenia e dorsalgia com três meses de evolução. A investigação revelou múltiplas lesões ósseas focais osteolíticas nas clavículas, costelas, crânio e coluna dorso-lombo-sagrada, sem evidência de anemia, hipercalcemia ou insuficiência renal, sem imunofixação anormal no soro ou na urina e com rácios de cadeias leves livres normais. O aspirado e biópsia de medula óssea da crista ilíaca revelou um escasso envolvimento por plasmócitos. No entanto, a biópsia de uma das lesões focais revelou uma medula hipercelular com plasmócitos fenotipicamente anormais e com uma aberrante expressão de citoqueratinas. O mieloma múltiplo não-secretor é por si só um diagnóstico raro. Contudo, a combinação de envolvimento irregular da medula e a expressão aberrante de citoqueratinas são merecedoras de atenção.

Fibroma no osificante / Non-ossifying fibroma

RESUMEN Fundamento: el fibroma no osificante es una tumoración ósea benigna que afecta a adolescentes y jóvenes, la presentación clínica varía de una forma asintomática hasta la presencia de fractura patológica. En la literatura nacional no existe mucha información sobre esta lesión ósea. Objetivo: actualizar los conocimientos en relación a esta afección ósea. Métodos: la búsqueda y análisis de la información se realizó en un periodo de cuatro meses (primero de junio 2020 al 30 de septiembre de 2020) y se emplearon las siguientes palabras: nonossifyng fibroma, y fibrous cortical defect. A partir de la información obtenida se realizó una revisión bibliográfica de un total de 247 artículos publicados en las bases de datos PubMed, Hinari, SciELO y Medline mediante el gestor de búsqueda y administrador de referencias EndNote, de ellos se utilizaron 40 citas seleccionadas para realizar la revisión, de ellas 38 de los últimos cinco años, además se consultaron cuatro libros. Resultados: se menciona la localización más frecuente, así como las formas de presentación clínica. Se describen los estudios imagenológicos y la interpretación de sus resultados. Con relación al diagnóstico diferencial se comparan una serie de enfermedades con características clínicas e imagenológicas muy similares. Se hace referencia a las características macro y microscópicas, además del tipo de tratamiento y complicaciones. Conclusiones: el fibroma no osificante es una enfermedad que se presenta con relativa frecuencia. Las características imagenológicas son típicas y resalta entre ellas la excentricidad de la lesión. El tratamiento depende de cada lesión y transita desde la simple observación a la intervención quirúrgica.

ABSTRACT Background: non-ossifying fibroma is a benign tumor that affects adolescents and young people, the clinical presentation varies asymptomatically until the presence of a pathological fracture. In the national literature there is not much information about this bone lesion. Objective: to update knowledge in relation to this bone lesion. Methods: the search and analysis of the information was performed over a period of four months (June 1st, 2020 to September 30th, 2020) and the following words were used: non-ossifying fibroma, and fibrous cortical defect. From the information obtained, a bibliographic review of a total of 247 articles published in the PubMed, Hinari, SciELO and Medline databases was carried out using the search manager and EndNote reference manager, of which 40 selected citations were used to perform the review, 38 of them of the last five year, four books were consulted. Results: the most frequent location is mentioned, as well as the clinical presentation forms. Imaging studies and the interpretation of their results are described. In relation to the differential diagnosis, a series of entities with very similar clinical and imaging characteristics are compared. Reference is made to the macro and microscopic characteristics, in addition to the type of treatment and complications. Conclusions: the non-ossifying fibroma is an entity that presents itself with relative frequency. The imaging characteristics are typical and eccentricity of the lesion stands out among them. The treatment depends on the lesion and goes from the simple observation to the surgical one.

Pathological fracture after radiotherapy: systematic review of literature

SUMMARY OBJECTIVE: To evaluate the epidemiological data and available treatments for fractures secondary to radiotherapy treatment. METHODS: Identification of publications on pathological skeletal fractures previously exposed to ionizing radiation. RESULTS: The incidence of fractures after irradiation varies from 1.2% to 25% with a consolidation rate of 33% to 75%, being more frequent in the ribs, pelvis, and femur. The time elapsed between irradiation and fracture occurs years after radiotherapy. Risk factors include age above 50 years, female gender, extensive periosteal detachment, circumferential irradiation, tumor size, and anterior thigh location. The etiology is still uncertain, but cellular disappearance, reduction of bone turnover and activity were observed hematopoietic as possible causes of failure of consolidation. CONCLUSION: There is no consensus in the literature on the factors related to the development of fractures, with radiation dose, previous tumor size and periosteal detachment being suggested as potential factors.

RESUMO OBJETIVO: Avaliar dados epidemiológicos e tratamentos disponíveis para fraturas secundárias ao tratamento radioterápico. MÉTODOS: Identificação de publicações sobre as fraturas patológicas ocorridas em esqueleto previamente exposto à radiação ionizante. RESULTADOS: A incidência de fraturas após irradiação varia de 1,2% a 25% com taxa de consolidação de 33% a 75%, sendo mais frequente em costelas, pelve e fêmur. O tempo decorrido entre a irradiação e a fratura ocorre anos após a radioterapia. Os fatores de risco incluem idade acima de 50 anos, sexo feminino, descolamento periosteal extenso, irradiação circunferencial, tamanho do tumor e localização anterior na coxa. A etiologia ainda é incerta, mas foram observados desaparecimento celular, redução do turnover ósseo e da atividade hematopoiética como possíveis causas da falha de consolidação. CONCLUSÃO: Não há consenso na literatura avaliada sobre os fatores relacionados ao desenvolvimento de fraturas, sendo a dose de radiação, o tamanho prévio do tumor e o descolamento periosteal sugeridos como fatores potenciais.

[Photodynamic intramedullary bone stabilization of pathological fractures]. / Fotodynamische intramedulläre Knochenstabilisierung bei pathologischen Frakturen.

Pathological fractures of long tubular bones are stabilized with conventional implants. Essentially, plates and intramedullary nails are used for stabilization and are two different techniques, which compete with each other with respect to the surgical treatment. A large number of such means of osteosynthesis are commercially available but are primarily focused on acute fractures in otherwise biologically healthy bones. The pathological fracture or the treatment of impending pathological fractures due to metastatic osteolysis differs from the treatment of healthy bones in some fundamental aspects. The characteristics of pathological fractures make the development of new technologies that meet the specific needs of both the patient and the surgeon desirable. A new approach in treatment is stabilization of internal long bone fractures by the use of a cylindrical balloon implant, which is introduced into the bone via a small proximal or distal hole and then filled and expanded to a much larger diameter with a liquid monomer. The curing process is initiated with the application of blue light forming a rigid implant by polymerization (IlluminOss™). Many of the well-known disadvantages of conventional implants can be eliminated with this technology. Specifically, with respect to the irregular shape of the natural medullary canal it is possible to completely fill the medullary canal of the tubular bone. The filling of the canal provides torsional stability without the use of interlocking screws. Similarly, the use of the balloon technique enables minimally invasive surgery and furthermore permits the additive use of conventional metallic plates whenever necessary. The new balloon techniques show high primary stability in the treatment of pathological shaft fractures. In particular cases, the addition of a supplemental plate osteosynthesis is recommended.

Metástasis óseas: enfoque ortopédico / Bone metastasis: orthopedic point of view

RESUMEN Fundamento: el cáncer constituye una causa frecuente de morbi-mortalidad a nivel internacional y nacional. Dentro de las formas de presentación se encuentran las metástasis óseas. Objetivo: profundizar los conocimientos de la enfermedad ósea metastásica enfocada en el manejo desde el punto de vista de la especialidad de Ortopedia y Traumatología. Métodos: la búsqueda de la información se realizó en un periodo de tres meses (primero de enero de 2018 al 31 de marzo de 2018) y se emplearon las siguientes palabras: bone metastasis, pathologic fracture, y metastasic bone disease, a partir de la información obtenida se realizó una revisión bibliográfica de un total de 259 artículos publicados en las bases de datos PubMed, Hinari, SciELO y Medline mediante el gestor de búsqueda y administrador de referencias EndNote, de ellos se utilizaron 50 citas seleccionadas para realizar la revisión, de ellas 41 de los últimos cinco años, se incluyeron diez libros. Desarrollo: se describen las metástasis óseas de acuerdo a su aspecto radiográfico en blásticas, líticas y mixtas; así como los principales sitios de origen. Se hace referencia a los principales estadios, con especial énfasis en el riesgo de fractura patológica, para lo que se plasman criterios, que permiten definir la conducta a seguir. Se mencionan las indicaciones y variantes del tratamiento quirúrgico, así como el pronóstico de estos enfermos. Conclusiones: la enfermedad ósea metastásica es un reto para el cirujano ortopédico, tiene indicaciones quirúrgicas específicas y uno de los elementos de más importancia es definir el riesgo de fractura patológica.

ABSTRACT Background: cancer is a common cause of morbidity-mortality affecting many people internationally and nationally. One way of presentation is bone metastases. Objective: to deepen the knowledge about the management of patients suffering from bone metastasis from a point of view of the Orthopedics and Traumatology specialties. Methods: a search of information was carried out in a period of three months (January 1st, 2018 to March 31st, 2018) in the databases PubMed, Hinari, SciELO and Medline through the information locator EndNote by using the words bone metastasis, pathologic fracture, and metastatic bone disease, resulting in a total of 259 articles which 50 of them were selected for the review, 41 of them of the last five years, including ten books. Development: bone metastasis types were described according to radiographic aspects as: litic, blastic and mix, so like the most common origin sites. The main stages were shown, specially the one related to the risk of pathologic fracture, so that criteria were stated to define treatment. Indication and treatment modalities were described, as well as prognostic factors. Conclusions: metastatic bone disease is a great challenge for orthopedic surgeon, there are specific indications for surgery and one of the most important aspects to take in mind is the risk of pathologic fracture.

Bone metastasis as the first symptom of tumors: role of an immunohistochemistry study in establishing primary tumor / Metástase óssea como primeira manifestação de tumores: contribuição do estudo imuno-histoquímico para o estabelecimento do tumor primário

ABSTRACT Objectives: To determine the role of immunohistochemistry in identifying the primary site of tumors, and in establishing which bones are most frequently involved, their relationship with the primary tumor site, and the rate of pathologic bone fracture as the first symptom of a malignant tumor. Methods: A retrospective analysis of all medical records on bone metastases the cases treated between January 2006 and December 2011 at the Department of Orthopedics and Traumatology was performed. Results: Immunohistochemistry correctly determined the primary tumor site in 61.2% of cases analyzed. Regarding the metastatic site, the most affected bone was the femur, accounting for 49.6% of the sample. Bone metastasis was the first symptom of the tumor in only 20.2% of patients, and of these, 95% were admitted for pathologic bone fracture. Conclusion: The study showed that the primary sites and their incidence rate are consistent with the literature reviewed. It was noted that in this sample, most patients did not present with pathologic bone fracture as the first clinical symptom of neoplastic disease. However, analysis of those patients that had a metastasis as the first clinical symptom revealed that it manifested itself as a pathologic fracture in almost all cases. The immunohistochemical study was consistent with the primary tumor site in most cases, indicating the value of the method in the detection of the primary site.

RESUMO Objetivos: Determinar a contribuição do estudo imuno-histoquímico na identificação do sítio primário da neoplasia, além de estabelecer quais os ossos mais frequentemente comprometidos, sua relação com o sítio primário neoplásico e a frequência de fratura em osso patológico como primeira manifestação do tumor maligno. Métodos: Foram levantados, retrospectivamente, todos os prontuários de metástases ósseas de janeiro de 2006 a dezembro de 2011 do Departamento de Ortopedia e Traumatologia. Resultados: O estudo imuno-histoquímico determinou corretamente o sítio primário neoplásico em 61,2% dos casos analisados. Com relação à localização metastática, o osso mais acometido foi o fêmur, correspondeu a 49,6% da amostra. A metástase óssea foi a primeira manifestação da neoplasia em apenas 20,2% dos pacientes; desses, 95% deram entrada com quadro de fratura do osso patológico. Conclusão: O estudo evidenciou que os sítios primários e sua frequência de incidência são compatíveis com a literatura avaliada. Observou-se que, na presente amostra, a maior parte dos pacientes não apresentou a fratura do osso patológico como primeira manifestação clínica da doença neoplásica. Entretanto, quando analisados os pacientes que apresentaram como primeiro sintoma clínico a metástase, essa se manifestou por meio de fratura patológica em quase todos os pacientes. O estudo imuno-histoquímico foi compatível com o sítio primário neoplásico na maioria dos casos, demonstrou a relevância de tal método no auxílio da identificação do sítio primário.

Bone metastasis as the first symptom of tumors: role of an immunohistochemistry study in establishing primary tumor.

OBJECTIVES: To determine the role of immunohistochemistry in identifying the primary site of tumors, and in establishing which bones are most frequently involved, their relationship with the primary tumor site, and the rate of pathologic bone fracture as the first symptom of a malignant tumor. METHODS: A retrospective analysis of all medical records on bone metastases the cases treated between January 2006 and December 2011 at the Department of Orthopedics and Traumatology was performed. RESULTS: Immunohistochemistry correctly determined the primary tumor site in 61.2% of cases analyzed. Regarding the metastatic site, the most affected bone was the femur, accounting for 49.6% of the sample. Bone metastasis was the first symptom of the tumor in only 20.2% of patients, and of these, 95% were admitted for pathologic bone fracture. CONCLUSION: The study showed that the primary sites and their incidence rate are consistent with the literature reviewed. It was noted that in this sample, most patients did not present with pathologic bone fracture as the first clinical symptom of neoplastic disease. However, analysis of those patients that had a metastasis as the first clinical symptom revealed that it manifested itself as a pathologic fracture in almost all cases. The immunohistochemical study was consistent with the primary tumor site in most cases, indicating the value of the method in the detection of the primary site.

OBJETIVOS: Determinar a contribuição do estudo imuno-histoquímico na identificação do sítio primário da neoplasia, além de estabelecer quais os ossos mais frequentemente comprometidos, sua relação com o sítio primário neoplásico e a frequência de fratura em osso patológico como primeira manifestação do tumor maligno. MÉTODOS: Foram levantados, retrospectivamente, todos os prontuários de metástases ósseas de janeiro de 2006 a dezembro de 2011 do Departamento de Ortopedia e Traumatologia. RESULTADOS: O estudo imuno-histoquímico determinou corretamente o sítio primário neoplásico em 61,2% dos casos analisados. Com relação à localização metastática, o osso mais acometido foi o fêmur, correspondeu a 49,6% da amostra. A metástase óssea foi a primeira manifestação da neoplasia em apenas 20,2% dos pacientes; desses, 95% deram entrada com quadro de fratura do osso patológico. CONCLUSÃO: O estudo evidenciou que os sítios primários e sua frequência de incidência são compatíveis com a literatura avaliada. Observou-se que, na presente amostra, a maior parte dos pacientes não apresentou a fratura do osso patológico como primeira manifestação clínica da doença neoplásica. Entretanto, quando analisados os pacientes que apresentaram como primeiro sintoma clínico a metástase, essa se manifestou por meio de fratura patológica em quase todos os pacientes. O estudo imuno-histoquímico foi compatível com o sítio primário neoplásico na maioria dos casos, demonstrou a relevância de tal método no auxílio da identificação do sítio primário.

A Young Female Athlete With Acute Low Back Pain Caused by Stage IV Breast Cancer.

OBJECTIVE: The purpose of this case report is to describe the case of a young female athlete with low back pain caused by metastatic breast cancer. CLINICAL FEATURES: A 27-year-old woman presented with low back pain after striking a ball during kickball 3 days earlier. Because of the mechanism of injury and onset, the patient was originally diagnosed with a lumbar spine sprain/strain. INTERVENTION/OUTCOME: After radiographs were obtained and were read as unremarkable, a 2-week trial of care was initiated that included soft-tissue mobilizations, anti-inflammatory medications from her primary care physician, and therapeutic rehabilitation exercises. After this trial concluded, the patient did not improve and continued to be in significant pain. Magnetic resonance imaging was then ordered and revealed an expansile lesion at L2 with cortical compromise. Referral to an oncologist prompted the diagnosis of stage IV breast cancer. CONCLUSION: Poor response to conservative treatment may indicate the working diagnosis is incorrect and that it must be reconsidered. In this case, a lack of response to care with persistent high severity of pain despite a multimodal approach justified further investigation with advanced imaging, which revealed spinal metastases secondary to breast cancer. Clinicians should be aware of history and physical exam indicators of red flag conditions that may present as low back pain.